Adamed nominated to the Prix Galien Award

The award ceremony of the first Polish edition of Prix Galien Polska 2012 will be held on November 20th in Warsaw. The Adamed Group is one of the Polish pharmaceutical and medical companies to be nominated for the award in the Innovative Research category. 

For the past 40 years, every year in several countries around the world, institutions and companies participate in the prestigious Prix Galien. Its aim is to reward those that present breakthrough achievements in the pharmaceutical and medical industries. It is an international event organized in 12 countries: France, Spain, United Kingdom, Germany, Holland, Belgium, Luxembourg, Portugal, Switzerland, Italy, United States and Canada. In 2012, the Prix Galien will also be held in Poland, Israel, Turkey and South Africa. The first Polish edition comprises 12 nominations in 4 categories. The Adamed Group has been nominated in the Innovative Research category for its ONCO 3-CLA project.   

Maciej Adamkiewicz, President of the Adamed Group: We are proud that our company has been considered for such a prestigious, international award like Prix Galien. We are currently conducting research in areas of oncology, neuropsychiatry and metabolic diseases.  Such projects are conducted thanks to the involvement of many people - research teams that cooperate with our company. Innovations are rarely the work of lone geniuses; they are rather fruits of the work done by interdisciplinary teams.

Winner will be announced during the official Prix Galien awards ceremony, which will be held on November 20th in Hotel Intercontinental in Warsaw.